Microencapsulated cell tracking

NMR in Biomedicine

Volumn 26, Issue 7, 2013, Pages 850-859

  Arifin, Dian R ^a   Kedziorek, Dorota A ^a   Fu, Yingli ^a   Chan, Kannie W Y ^a   Mcmahon, Michael T ^a   Weiss, Clifford R ^a   Kraitchman, Dara L ^a   Bulte, Jeff W M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell therapy; Computed tomography; Contrast agent; Diabetes; Islet cell transplantation; Microcapsules; MRI; Ultrasound imaging

Indexed keywords

CELL THERAPY; CONTRAST AGENT; ISLET CELLS; MICROCAPSULES; ULTRASOUND IMAGING;

CELLS; COMPUTERIZED TOMOGRAPHY; IMAGING TECHNIQUES; MAGNETIC RESONANCE IMAGING; MEDICAL PROBLEMS; MICROENCAPSULATION; ULTRASONIC IMAGING;

CYTOLOGY;

ALGINIC ACID; CALCIUM ION; GADOLINIUM; GOLD NANOPARTICLE; POLYCATION; STREPTOZOCIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ALOPECIA; ARTICLE; CARDIOMYOPLASTY; CELL SUSPENSION; CELL TRACKING; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CROSS LINKING; CYTOTOXICITY; DIABETES MELLITUS; EPITHELIUM CELL; ERECTILE DYSFUNCTION; FLUORINE NUCLEAR MAGNETIC RESONANCE; HEART INFARCTION; HUMAN; HUNTINGTON CHOREA; LIVER CELL; LIVER FAILURE; MESENCHYMAL STEM CELL; MICROCAPSULE; MICROENCAPSULATION; MONOCYTE; MYOBLAST; PARKINSON DISEASE; PRIORITY JOURNAL; RADIOGRAPHY; STEM CELL TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; XENOGRAFT;

ANIMALS; CAPSULES; CELL TRACKING; CONTRAST MEDIA; DEXTRANS; DRUG COMPOUNDING; HUMANS; MAGNETIC PHENOMENA; MAGNETITE NANOPARTICLES;

EID: 84879539239     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2894     Document Type: Article

References (67)

1. Aguayo-Mazzucato C, Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2010; 6(3): 139-148.
2. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011; 42(3): 825-829.
3. Donndorf P, Strauer BE, Steinhoff G. Update on cardiac stem cell therapy in heart failure. Curr. Opin. Cardiol. 2012; 27(2): 154-160.
4. Yoo BY, Shin YH, Yoon HH, Seo YK, Song KY, Park JK. Application of mesenchymal stem cells derived from bone marrow and umbilical cord in human hair multiplication. J. Dermatol. Sci. 2010; 60(2): 74-83.
5. Lin CS, Xin ZC, Wang Z, Deng C, Huang YC, Lin G, Lue TF. Stem cell therapy for erectile dysfunction: a critical review. Stem Cells Dev. 2012; 21(3): 343-351.
6. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 2006; 355(13): 1318-1330.
7. Hafiz MM, Faradji RN, Froud T, Pileggi A, Baidal DA, Cure P, Ponte G, Poggioli R, Cornejo A, Messinger S, Ricordi C, Alejandro R. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation 2005; 80(12): 1718-1728.
8. Hering BJ, Wijkstrom M, Graham ML, Hardstedt M, Aasheim TC, Jie T, Ansite JD, Nakano M, Cheng J, Li W, Moran K, Christians U, Finnegan C, Mills CD, Sutherland DE, Bansal-Pakala P, Murtaugh MP, Kirchhof N, Schuurman HJ. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat. Med. 2006; 12(3): 301-303.
9. Hering BJ, Cooper DK, Cozzi E, Schuurman HJ, Korbutt GS, Denner J, O'Connell PJ, Vanderpool HY, Pierson RN, IIIrd. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - executive summary. Xenotransplantation 2009; 16(4): 196-202.
10. Pierson RN, IIIrd, Dorling A, Ayares D, Rees MA, Seebach JD, Fishman JA, Hering BJ, Cooper DK. Current status of xenotransplantation and prospects for clinical application. Xenotransplantation 2009; 16(5): 263-280.
11. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210(4472): 908-910.
12. Toso C, Oberholzer J, Ceausoglu I, Ris F, Rochat B, Rehor A, Bucher P, Wandrey C, Schuldt U, Belenger J, Bosco D, Morel P, Hunkeler D. Intra-portal injection of 400-micron microcapsules in a large-animal model. Transpl. Int. 2003; 16(6): 405-410.
13. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Sandford PA. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343(8903): 950-951.
14. Tuch BE, Keogh GW, Williams LJ, Wu W, Foster JL, Vaithilingam V, Philips R. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009; 32(10): 1887-1889.
15. Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 2007; 14(2): 157-161.
16. Mai G, Huy NT, Morel P, Mei J, Andres A, Bosco D, Baertschiger R, Toso C, Berney T, Majno P, Mentha G, Trono D, Buhler LH. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Xenotransplantation 2005; 12(6): 457-464.
17. Borlongan CV, Thanos CG, Skinner SJ, Geaney M, Emerich DF. Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease. Cell Transplant. 2008; 16(10): 987-992.
18. Kishima H, Poyot T, Bloch J, Dauguet J, Conde F, Dolle F, Hinnen F, Pralong W, Palfi S, Deglon N, Aebischer P, Hantraye P. Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons. Neurobiol. Dis. 2004; 16(2): 428-439.
19. Visted T, Furmanek T, Sakariassen P, Foegler WB, Sim K, Westphal H, Bjerkvig R, Lund-Johansen M. Prospects for delivery of recombinant angiostatin by cell-encapsulation therapy. Hum. Gene Ther. 2003; 14(15): 1429-1440.
20. Paul A, Ge Y, Prakash S, Shum-Tim D. Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy. Regen. Med. 2009; 4(5): 733-745.
21. Dubrot J, Portero A, Orive G, Hernandez RM, Palazon A, Rouzaut A, Perez-Gracia JL, Hervas-Stubbs S, Pedraz JL, Melero I. Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells. Cancer Immunol. Immunother. 2010; 59(11): 1621-1631.
22. Patel AS, Smith A, Attia RQ, Mattock K, Humphries J, Lyons O, Saha P, Modarai B, Jayasinghe SN. Encapsulation of angiogenic monocytes using bio-spraying technology. Integr. Biol. (Camb.) 2012; 4(6): 628-632.
23. Kedziorek DA, Hofmann LV, Fu Y, Gilson WD, Cosby KM, Kohl B, Barnett BP, Simons BW, Walczak P, Bulte JW, Gabrielson K, Kraitchman DL. X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease. Stem Cells 2012; 30(6): 1286-1296.
24. Lohr M, Hoffmeyer A, Kroger J, Freund M, Hain J, Holle A, Karle P, Knofel WT, Liebe S, Muller P, Nizze H, Renner M, Saller RM, Wagner T, Hauenstein K, Gunzburg WH, Salmons B. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 2001; 357(9268): 1591-1592.
25. Arifin DR, Bulte JW. Imaging of pancreatic islet cells. Diabetes Metab. Res. Rev. 2011; 27(8): 761-766.
26. Hernandez RM, Orive G, Murua A, Pedraz JL. Microcapsules and microcarriers for in situ cell delivery. Adv. Drug Deliv. Rev. 2010; 62(7-8): 711-730.
27. Strand BL, Ryan TL, In't Veld P, Kulseng B, Rokstad AM, Skjak-Brek G, Espevik T. Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant. 2001; 10(3): 263-275.
28. Clayton HA, London NJ, Colloby PS, Bell PR, James RF. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. J. Microencapsul. 1991; 8(2): 221-233.
29. Vandenbossche GM, Bracke ME, Cuvelier CA, Bortier HE, Mareel MM, Remon JP. Host reaction against alginate-polylysine microcapsules containing living cells. J. Pharm. Pharmacol. 1993; 45(2): 121-125.
30. Vandenbossche GM, Bracke ME, Cuvelier CA, Bortier HE, Mareel MM, Remon JP. Host reaction against empty alginate-polylysine microcapsules. Influence of preparation procedure. J. Pharm. Pharmacol. 1993; 45(2): 115-120.
31. De Vos P, De Haan B, Van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 1997; 18(3): 273-278.
32. King A, Strand B, Rokstad AM, Kulseng B, Andersson A, Skjak-Braek G, Sandler S. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J. Biomed. Mater. Res. A 2003; 64(3): 533-539.
33. King A, Sandler S, Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. J. Biomed. Mater. Res. 2001; 57(3): 374-383.
34. Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. 1997; 4(9): 961-968.
35. Thu MS, Bryant LH, Coppola T, Jordan EK, Budde MD, Lewis BK, Chaudhry A, Ren J, Varma NR, Arbab AS, Frank JA. Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat. Med. 2012; 18(3): 463-467.
36. Arifin DR, Long CM, Gilad AA, Alric CE, Roux S, Tillement O, Link TW, Arepally A, Bulte JWM. Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can be tracked by using US, CT, and positive-contrast MR imaging. Radiology 2011; 260(3): 790-798.
37. Arifin DR, Manek S, Call E, Arepally A, Bulte JW. Microcapsules with intrinsic barium radiopacity for immunoprotection and X-ray/CT imaging of pancreatic islet cells. Biomaterials 2012; 33(18): 4681-4689.
38. Barnett BP, Kraitchman DL, Lauzon C, Magee CA, Walczak P, Gilson WD, Arepally A, Bulte JW. Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol. Pharmacol. 2006; 3(5): 531-538.
39. Kim J, Arifin DR, Muja N, Kim T, Gilad AA, Kim H, Arepally A, Hyeon T, Bulte JWM. Multifunctional capsule-in-capsules for immunoprotection and trimodal imaging. Angew. Chem. Int. Ed Engl. 2011; 50(10): 2317-2321.
40. Barnett BP, Arepally A, Karmarkar PV, Qian D, Gilson WD, Walczak P, Howland V, Lawler L, Lauzon C, Stuber M, Kraitchman DL, Bulte JW. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat. Med. 2007; 13(8): 986-991.
41. Link TW, Woodrum D, Gilson WD, Pan L, Qian D, Kraitchman DL, Bulte JW, Arepally A, Weiss CR. MR-guided portal vein delivery and monitoring of magnetocapsules: assessment of physiologic effects on the liver. J. Vasc. Interv. Radiol. 2011; 22(9): 1335-1340.
42. Mills PH, Hitchens TK, Foley LM, Link T, Ye Q, Weiss CR, Thompson JD, Gilson WD, Arepally A, Melick JA, Kochanek PM, Ho C, Bulte JW, Ahrens ET. Automated detection and characterization of SPIO-labeled cells and capsules using magnetic field perturbations. Magn. Reson. Med. 2012; 67(1): 278-289.
43. Link TW, Arifin DR, Long CM, Walczak P, Muja N, Arepally A, Bulte JWM. Use of magnetocapsules for in vivo visualization and enhanced survival of xenogeneic HepG2 cell transplants. Cell Med. 2012; 4(2): 77-84.
44. Barnett BP, Ruiz-Cabello J, Hota P, Liddell R, Walczak P, Howland V, Chacko VP, Kraitchman DL, Arepally A, Bulte JW. Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging. Radiology 2011; 258(1): 182-191.
45. Barnett BP, Arepally A, Stuber M, Arifin DR, Kraitchman DL, Bulte JWM. Synthesis of magnetic resonance-, X-ray- and ultrasound-visible alginate microcapsules for immunoisolation and noninvasive imaging of cellular therapeutics. Nat. Protoc. 2011; 6(8): 1142-1151.
46. Lardo AC. Real-time magnetic resonance imaging: diagnostic and interventional applications. Pediatr. Cardiol. 2000; 21(1): 80-98.
47. Lederman RJ. Cardiovascular interventional magnetic resonance imaging. Circulation 2005; 112(19): 3009-3017.
48. Liddell RP, Patel TH, Weiss CR, Lee DS, Matsuhashi T, Brown PR, Gabrielson KL, Rodriguez ER, Eng J, Kimura H, Hofmann LV. Endovascular model of rabbit hindlimb ischemia: a platform to evaluate therapeutic angiogenesis. J. Vasc. Interv. Radiol. 2005; 16(7): 991-998.
49. Zimmermann U, Mimietz S, Zimmermann H, Hillgartner M, Schneider H, Ludwig J, Hasse C, Haase A, Rothmund M, Fuhr G. Hydrogel-based non-autologous cell and tissue therapy. Biotechniques 2000; 29(3): 564-572.
50. Bulte JWM. In vivo MRI cell tracking: clinical studies. Am. J. Roentgenol. 2009; 193(2): 314-325.
51. Shen F, Li AA, Gong YK, Somers S, Potter MA, Winnik FM, Chang PL. Encapsulation of recombinant cells with a novel magnetized alginate for magnetic resonance imaging. Hum. Gene Ther. 2005; 16(8): 971-984.
52. Shen F, Poncet-Legrand C, Somers S, Slade A, Yip C, Duft AM, Winnik FM, Chang PL. Properties of a novel magnetized alginate for magnetic resonance imaging. Biotechnol. Bioeng. 2003; 83(3): 282-292.
53. Stuber M, Gilson WD, Schar M, Kedziorek DA, Hofmann LV, Shah S, Vonken EJ, Bulte JW, Kraitchman DL. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn. Reson. Med. 2007; 58(5): 1072-1077.
54. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 2005; 23(8): 983-987.
55. Bulte JW. Hot spot MRI emerges from the background. Nat. Biotechnol. 2005; 23(8): 945-946.
56. Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW. In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn. Reson. Med. 2008; 60(6): 1506-1511.
57. 19F magnetic resonance imaging. J. Magn. Reson. 1977; 28: 133-136.
58. 19F) MRS and MRI in biomedicine. NMR Biomed. 2011; 24(2): 114-129.
59. 19F-MRI in vivo determination of the partial oxygen pressure in perfluorocarbon-loaded alginate capsules implanted into the peritoneal cavity and different tissues. Magn. Reson. Med. 1999; 42(6): 1039-1047.
60. Barnett BP, Ruiz-Cabello J, Hota P, Ouwerkerk R, Shamblott MJ, Lauzon C, Walczak P, Gilson WD, Chacko VP, Kraitchman DL, Arepally A, Bulte JWM. Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol. I, 2011; 6(4): 251-259.
61. Isaka M, Imamura M, Sakuma I, Shiiya N, Fukushima S, Nakai K, Kitabatake A, Yasuda K. Cardioprotective effect of perfluorochemical emulsion for cardiac preservation after six-hour cold storage. ASAIO J. 2005; 51(4): 434-439.
62. Rosen NA, Hopf HW, Hunt TK. Perflubron emulsion increases subcutaneous tissue oxygen tension in rats. Wound Repair Regen. 2006; 14(1): 55-60.
63. Voiglio EJ, Zarif L, Gorry FC, Krafft MP, Margonari J, Martin X, Riess J, Dubernard JM. Aerobic preservation of organs using a new perflubron/lecithin emulsion stabilized by molecular dowels. J. Surg. Res. 1996; 63(2): 439-446.
64. Khattak SF, Chin KS, Bhatia SR, Roberts SC. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol. Bioeng. 2007; 96(1): 156-166.
65. Cormode DP, Mulder WJ, Fayad ZA. Science to practice: versatile method to track transplanted encapsulated islet cells with multiple imaging modalities. Radiology 2011; 258(1): 1-2.
66. Alric C, Taleb J, Le Duc G, Mandon C, Billotey C, Le Meur-Herland A, Brochard T, Vocanson F, Janier M, Perriat P, Roux S, Tillement O. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J. Am. Chem. Soc. 2008; 130(18): 5908-5915.
67. Kiessling FM. Science to practice: are theranostic agents with encapsulated cells the key for diabetes therapy? Radiology 2011; 260(3): 613-615.